Individual Neurophysiological Sensory Profiles in People With and Without Neurodevelopmental Disorders
SensAUry
1 other identifier
observational
200
0 countries
N/A
Brief Summary
The goal of this observational study is to evaluate intra-individual neurophysiological variability in children and adults with and without NeuroDevelopmental Disorders (NDD), for several sensory modalities and types of stimulation. The main hypotheses are:
- NDD participants and children exhibit higher intra-individual variability than other participants
- intra-individual neurophysiological variability is correlated to behavioral, psychological and learning profiles Participants in this study will:
- be recorded for EEG and other neurophysiological parameters while exposed to sensory stimulations, to quantify sensory neurophysiological variability
- perform behavioral tests and fill out questionnaires, to establish the behavioral and psychological profile
- train for perceptual learning, to measure learning abilities These evaluations will be split in 3 visits spread on a maximum of 3 months, and training for learning will be done at home in between 2 visits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2026
CompletedStudy Start
First participant enrolled
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 15, 2028
April 21, 2026
April 1, 2026
1 month
March 26, 2026
April 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Amplitude of central neurophysiological responses to sensory stimulations
Amplitude (in micro-volts) of event-related potentials
Through study completion, an average of 2 months per participant
Latency of central neurophysiological responses to sensory stimulations
Latency (in milli-seconds) of event-related potentials
Through study completion, an average of 2 months per participant
Variability of central neurophysiological responses to sensory stimulations
Intra-individual variability (in percentage) of event-related potentials
Through study completion, an average of 2 months per participant
Secondary Outcomes (12)
Visual perceptual learning performance
Through study completion, an average of 2 months per participant
Auditory perceptual learning performance
Through study completion, an average of 2 months per participant
Behavioral sensory profile
Through study completion, an average of 2 months per participant
Sensory profile questionnaire
Through study completion, an average of 2 months per participant
Cognitive psychological profile
Through study completion, an average of 2 months per participant
- +7 more secondary outcomes
Study Arms (4)
Neurodevelopmental Disorders Children
6-12 years old children
Neurodevelopmental Disorders Adults
18-45 years old adults
Neurotypical Children
6-12 years old children
Neurotypical Adults
18-45 years old adults
Eligibility Criteria
Participants will be adults between 18 and 45 years old and children between 6 and 12 years old, with or without a Neurodevelopmental Disorder.
You may qualify if:
- Social security affiliation
- Free and written informed consent from the participants (Neurotypical Adults, NDD Adults without judicial protective measures), or their tutor or legal representant(s) (other participants)
- Age between 6 and 12 years included (Children) or between 18 and 45 years included (Adults)
- For NDD participants: NDD diagnosis by a qualified medical professional, according to DSM-4, DSM-5, ICD-10 or ICD-11 criteria
- Psychotropic medication perturbing EEG recording
- Drugs pertubing peripheral neurophysiological measures
- Non-corrected visual or auditory troubles
- Epilepsy
- For Neurotypical participants: NDD diagnosis
- For NDD participants: anticipated psychological or physical risk at participating, at the investigator's discretion
You may not qualify if:
- Participants with no data to evaluate Outcome 1
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2026
First Posted
April 21, 2026
Study Start
April 15, 2026
Primary Completion (Estimated)
May 15, 2026
Study Completion (Estimated)
April 15, 2028
Last Updated
April 21, 2026
Record last verified: 2026-04